Table 1 Demographic characteristics, lung function and responses to questionnaires of study population

Male/female, N

17/25

8/13

3/15

Age, years, mean ± SEM

30.12 ± 1.50

33.43 ± 2.10

34.06 ± 2.85

BMI, kg/m2

24.92 ± 1.03

25.95 ± 1.06

24.53 ± 0.81

Duration of rhinitis symptoms, years, mean ± SEM

10.71 ± 1.60

14.46 ± 2.27

N/A

Duration of asthma symptoms, years, mean ± SEM,

N/A

11.33 ± 2.80

N/A

FEV1, l, mean ± SEM

3.76 ± 0.14

3.50 ± 0.22

3.57 ± 0.16

FVC, l, mean ± SEM

4.34 ± 0.17

3.84 ± 0.22

4.12 ± 0.18

FEV1/FVC, %, l, mean ± SEM

84.40 ± 0.92

83.56 ± 1.33

82.85 ± 1.32

FEV1, % of predicted, mean ± SEM

98.58 ± 1.12

100.25 ± 2.27

106.00 ± 3.30

FVC, % of predicted, mean ± SEM

96.85 ± 1.29

97.00 ± 2.04

105.21 ± 3.44

TNSS, mean ± SEM

4.55 ± 0.36**

3.67 ± 0.50**

0.67 ± 0.30

ACT, mean ± SEM

N/A

19.19 ± 0.93

N/A

RQLQ, mean ± SEM

1.79 ± 0.19

1.38 ± 0.30

N/A

RQLQ domain—sleep

1.67 ± 0.30

1.62 ± 0.42

N/A

RQLQ domain—other symptoms

1.47 ± 0.22

1.40 ± 0.39

N/A

RQLQ domain—practical problems

2.22 ± 0.30^#

1.25 ± 0.36

N/A

RQLQ domain—nasal symptoms

2.18 ± 0.26

1.61 ± 0.35

N/A

RQLQ domain—ocular symptoms

1.27 ± 0.22

0.92 ± 0.21

N/A

RQLQ domain—activity

2.06 ± 0.20^#

1.31 ± 0.18

N/A

RQLQ domain—emotions

1.94 ± 0.23

1.39 ± 0.43

N/A

AQLQ, mean ± SEM

N/A

5.51 ± 0.28

N/A

PSQI, mean ± SEM

7.35 ± 0.57

7.75 ± 1.17

5.69 ± 0.52

PSQI component 1

1.22 ± 0.12

1.25 ± 0.14

0.88 ± 0.09

PSQI component 2

1.19 ± 0.15

1.31 ± 0.27

1.13 ± 0.22

PSQI component 3

0.78 ± 0.12

1.00 ± 0.24

1.00 ± 0.18

PSQI component 4

0.68 ± 0.14*

0.75 ± 0.27*

0.13 ± 0.09

PSQI component 5

1.46 ± 0.11

1.50 ± 0.16

1.13 ± 0.22

PSQI component 6

0.30 ± 0.14

0.50 ± 0.27

0.13 ± 0.13

PSQI component 7

1.73 ± 0.14

1.50 ± 0.30

1.31 ± 0.18

SIGH-A, mean ± SEM

10.86 ± 1.45

8.69 ± 2.80

9.19 ± 1.40